Aleksandra Obszańska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aleksandra Obszańska has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Julia Tesyna
4th Military Clinical Hospital with Polyclinic SPZOZ in Wrocław, ul. Rudolfa Weigla 5, 50-981 Wrocław
10 shared publications - Kamil Marchlik
4th Military Hospital in Wroclaw
10 shared publications - Karolina Kubala
Provincial Specialist Hospital named after J. Gromkowski Ul.Koszarowa 5, 51-149 Wrocław
8 shared publications - Jakub Tomczyszyn
Wojewódzki Szpital Specjalistyczny we Wrocławiu: Wroclaw, Lower Silesia, PL ul. H. M. Kamieńskiego 73a 51-124 Wrocław
7 shared publications - Melania Czapla
Faculty of Medicine, Wroclaw Medical University, Mikulicza-Radeckiego 5, 50-345 Wroclaw, Poland
7 shared publications - Antonina Gendasz
Wroclaw Medical University, 1 Ludwik Pasteur, 50-367 Wroclaw, Poland
3 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 78, 76177
Congenital Nephrotic Syndrome: Etiology, Clinical Presentation, and a Comparison of Optimal Treatment Strategies – A Literature Review
Introduction: Congenital nephrotic syndrome is a rare condition with symptom onset occurring within the first three months of life. It affects approximately 1 to 3 per 100,000 live births. It has a varied etiology on a genetic, non-genetic, and infectious basis. While management primarily relies on symptomatic care, advances in modern medicine have significantly improved long-term outcomes, slowly ensuring affected children normal functioning in the future. Aim: The primary aim of this literature review is to synthesize current knowledge regarding the etiology and clinical presentation of CNS, and to compare the efficacy of evolving therapeutic methods, contrasting conservative medical management with radical surgical and renal replacement strategies. Keywords: Congenital Nephrotic Syndrome; NPHS1 Gene; Nephrin; Glomerular Filtration Barrier; Bilateral Nephrectomy; Kidney Transplantation; Pediatric Nephrology. Materials and methods: This study is a narrative literature review based on the analysis of scientific articles concerning congenital nephrotic syndrome (CNS). The reviewed studies included neonates and infants with CNS, focusing on genetic causes, medical and surgical management (nephrectomy), and kidney transplantation outcomes. Clinical guidelines, literature reviews, meta-analyse, cohort studies, and case reports published between 2001 and 2026 were analyzed. Conclusions: Congenital nephrotic syndrome (CNS) lacks a universal treatment protocol, demanding a strictly personalized, multidisciplinary approach tailored to the unique clinical, metabolic, and genetic profile of each infant. Early prenatal detection is critical for planned delivery in tertiary centers and immediate postnatal stabilization. While contemporary management remains purely symptomatic and supportive, optimizing long-term outcomes requires expanded multicenter registries and a decisive shift in research toward causal, gene- and molecular-targeted therapies.
- 21 October 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 78, 76177
Open AccessCongenital Nephrotic Syndrome: Etiology, Clinical Presentation, and a Comparison of Optimal Treatment Strategies – A Literature Review
Introduction: Congenital nephrotic syndrome is a rare condition with symptom onset occurring within the first three months of life. It affects approximately 1 to 3 per 100,000 live births. It has a varied etiology on a genetic, non-genetic, and infectious basis. While management primarily relies on symptomatic care, advances in modern medicine have significantly improved long-term outcomes, slowly ensuring affected children normal functioning in the future. Aim: The primary aim of this literature review is to synthesize current knowledge regarding the etiology and clinical presentation of CNS, and to compare the efficacy of evolving therapeutic methods, contrasting conservative medical management with radical surgical and renal replacement strategies. Keywords: Congenital Nephrotic Syndrome; NPHS1 Gene; Nephrin; Glomerular Filtration Barrier; Bilateral Nephrectomy; Kidney Transplantation; Pediatric Nephrology. Materials and methods: This study is a narrative literature review based on the analysis of scientific articles concerning congenital nephrotic syndrome (CNS). The reviewed studies included neonates and infants with CNS, focusing on genetic causes, medical and surgical management (nephrectomy), and kidney transplantation outcomes. Clinical guidelines, literature reviews, meta-analyse, cohort studies, and case reports published between 2001 and 2026 were analyzed. Conclusions: Congenital nephrotic syndrome (CNS) lacks a universal treatment protocol, demanding a strictly personalized, multidisciplinary approach tailored to the unique clinical, metabolic, and genetic profile of each infant. Early prenatal detection is critical for planned delivery in tertiary centers and immediate postnatal stabilization. While contemporary management remains purely symptomatic and supportive, optimizing long-term outcomes requires expanded multicenter registries and a decisive shift in research toward causal, gene- and molecular-targeted therapies.
- Open Access
- 11 October 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 77, 76176
The Effect of Resistance Training on Bone Mineral Density in the Lumbar Spine and Femoral Neck in Postmenopausal Women - literature review.
Introduction: Osteoporosis is a chronic disease of the skeletal system characterised by reduced bone strength and an increased risk of fractures. In postmenopausal women, estrogen deficiency accelerates bone loss. Resistance training provides mechanical stimuli that may help maintain or increase bone mineral density (BMD). Materials and methods: A narrative review of randomized controlled trials, intervention studies, systematic reviews, and meta-analyses was conducted. The analysis focused on changes in BMD measured by dual-energy X-ray absorptiometry (DXA), particularly at the lumbar spine and femoral neck, considering training intensity, frequency, duration, and progression. Aim of the study: To evaluate the effects of resistance training on BMD in postmenopausal women and assess the influence of training characteristics on its effectiveness. Conclusions: Resistance training may increase BMD or attenuate its decline in postmenopausal women. The most consistent effects were observed at the lumbar spine, while findings for the femoral neck were more heterogeneous. Higher intensity and progressive loading may provide a stronger osteogenic stimulus, although no single optimal protocol has been established. Further research is needed to determine optimal training parameters and their impact on fracture risk.
- 11 October 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 77, 76176
Open AccessThe Effect of Resistance Training on Bone Mineral Density in the Lumbar Spine and Femoral Neck in Postmenopausal Women - literature review.
Introduction: Osteoporosis is a chronic disease of the skeletal system characterised by reduced bone strength and an increased risk of fractures. In postmenopausal women, estrogen deficiency accelerates bone loss. Resistance training provides mechanical stimuli that may help maintain or increase bone mineral density (BMD). Materials and methods: A narrative review of randomized controlled trials, intervention studies, systematic reviews, and meta-analyses was conducted. The analysis focused on changes in BMD measured by dual-energy X-ray absorptiometry (DXA), particularly at the lumbar spine and femoral neck, considering training intensity, frequency, duration, and progression. Aim of the study: To evaluate the effects of resistance training on BMD in postmenopausal women and assess the influence of training characteristics on its effectiveness. Conclusions: Resistance training may increase BMD or attenuate its decline in postmenopausal women. The most consistent effects were observed at the lumbar spine, while findings for the femoral neck were more heterogeneous. Higher intensity and progressive loading may provide a stronger osteogenic stimulus, although no single optimal protocol has been established. Further research is needed to determine optimal training parameters and their impact on fracture risk.
- Open Access
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75267
Exercise Volume and the Risk of Atrial Fibrillation in Athletes: A Literature Review
Background. Despite the proven positive effects of physical activity on the cardiovascular system, an increasing number of veteran athletes are being diagnosed with atrial fibrillation (AF). Over the past few decades, a growing body of evidence suggests that prolonged endurance training may contribute to the development of AF in certain groups of athletes. The recognition of this link has sparked a debate among researchers regarding the determination of the amount of training at which the risk of AF significantly increases. However, current research findings are inconsistent regarding this relationship; therefore, the relationship between training volume, the type of sport practiced, and the risk of arrhythmia remains not fully understood. Aim. This literature review aims to review the mechanisms involved in the development of atrial fibrillation in athletes and to evaluate the association between exercise volume and the risk of atrial fibrillation. Material and methods. A literature review was conducted using PubMed and Google Scholar. Meta-analyses, systematic reviews, randomized control trials, systematic and literature reviews from past 20 years were analyzed. Results. The strongest available evidence suggests that athletes have approximately 2.5 times the risk of AF compared to the general population. The available data suggest a U-shaped or J-shaped relationship between exercise and the risk of AF. Moderate physical activity still remains cardioprotective. Studies involving the population of female athletes remain limited. Conclusions. The relationship between the risk of AF and physical activity is complex and seems paradoxical. Moderate physical activity has a protective effect, while excessive training increases the risk of AF.
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75267
Open AccessExercise Volume and the Risk of Atrial Fibrillation in Athletes: A Literature Review
Background. Despite the proven positive effects of physical activity on the cardiovascular system, an increasing number of veteran athletes are being diagnosed with atrial fibrillation (AF). Over the past few decades, a growing body of evidence suggests that prolonged endurance training may contribute to the development of AF in certain groups of athletes. The recognition of this link has sparked a debate among researchers regarding the determination of the amount of training at which the risk of AF significantly increases. However, current research findings are inconsistent regarding this relationship; therefore, the relationship between training volume, the type of sport practiced, and the risk of arrhythmia remains not fully understood. Aim. This literature review aims to review the mechanisms involved in the development of atrial fibrillation in athletes and to evaluate the association between exercise volume and the risk of atrial fibrillation. Material and methods. A literature review was conducted using PubMed and Google Scholar. Meta-analyses, systematic reviews, randomized control trials, systematic and literature reviews from past 20 years were analyzed. Results. The strongest available evidence suggests that athletes have approximately 2.5 times the risk of AF compared to the general population. The available data suggest a U-shaped or J-shaped relationship between exercise and the risk of AF. Moderate physical activity still remains cardioprotective. Studies involving the population of female athletes remain limited. Conclusions. The relationship between the risk of AF and physical activity is complex and seems paradoxical. Moderate physical activity has a protective effect, while excessive training increases the risk of AF.
- Open Access
- 22 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 75, 75999
The Growing Importance of CA 19-9 in the Diagnosis and Monitoring of Malignant Ovarian Tumors
Aim: Managing ovarian tumors is a clinical challenge due to vague symptoms, especially in young patients and athletes where saving fertility and avoiding invasive protocols are vital to healthcare quality. This study evaluates the diagnostic and monitoring role of Carbohydrate Antigen 19-9 (CA 19-9) across ovarian tumor histotypes to optimize clinical decisions and patient outcomes. Materials and Methods: A comprehensive review of literature and clinical cohorts evaluating CA 19-9 expression in epithelial ovarian cancers (serous, endometrioid, clear cell, mucinous) and germ cell tumors (mature cystic teratomas) was conducted. Databases were searched for English- and Polish-language studies published up to May 2026. Diagnostic indices, including sensitivity, specificity, and multi-marker panels (CA 19-9 combined with CA 125/HE4), were extracted and synthesized using a narrative approach across core clinical domains. Results: While CA 125 is standard for serous carcinomas, it shows poor sensitivity in clear cell and mucinous histotypes. Conversely, CA 19-9 levels are significantly elevated in mucinous carcinomas (>37 U/mL) and serve as an independent postoperative prognostic marker in clear cell carcinomas when CA 125 is normal. In endometrioid carcinomas, combining CA 19-9 and CA 125 yields a robust specificity of up to 90%. Furthermore, isolated CA 19-9 elevation in mature cystic teratomas strongly correlates with increased tumor size and thinning cyst walls, serving as a vital indicator to estimate acute adnexal torsion risks during physical strain. Conclusions: Integrating CA 19-9 into gynecological panels improves pre-operative differential diagnosis, reduces false-positive rates in active populations, and provides vital risk stratification for ovarian torsion. This multi-marker approach enhances healthcare quality and diagnostic safety in sports medicine and gynecological oncology.
- 22 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 75, 75999
Open AccessThe Growing Importance of CA 19-9 in the Diagnosis and Monitoring of Malignant Ovarian Tumors
Aim: Managing ovarian tumors is a clinical challenge due to vague symptoms, especially in young patients and athletes where saving fertility and avoiding invasive protocols are vital to healthcare quality. This study evaluates the diagnostic and monitoring role of Carbohydrate Antigen 19-9 (CA 19-9) across ovarian tumor histotypes to optimize clinical decisions and patient outcomes. Materials and Methods: A comprehensive review of literature and clinical cohorts evaluating CA 19-9 expression in epithelial ovarian cancers (serous, endometrioid, clear cell, mucinous) and germ cell tumors (mature cystic teratomas) was conducted. Databases were searched for English- and Polish-language studies published up to May 2026. Diagnostic indices, including sensitivity, specificity, and multi-marker panels (CA 19-9 combined with CA 125/HE4), were extracted and synthesized using a narrative approach across core clinical domains. Results: While CA 125 is standard for serous carcinomas, it shows poor sensitivity in clear cell and mucinous histotypes. Conversely, CA 19-9 levels are significantly elevated in mucinous carcinomas (>37 U/mL) and serve as an independent postoperative prognostic marker in clear cell carcinomas when CA 125 is normal. In endometrioid carcinomas, combining CA 19-9 and CA 125 yields a robust specificity of up to 90%. Furthermore, isolated CA 19-9 elevation in mature cystic teratomas strongly correlates with increased tumor size and thinning cyst walls, serving as a vital indicator to estimate acute adnexal torsion risks during physical strain. Conclusions: Integrating CA 19-9 into gynecological panels improves pre-operative differential diagnosis, reduces false-positive rates in active populations, and provides vital risk stratification for ovarian torsion. This multi-marker approach enhances healthcare quality and diagnostic safety in sports medicine and gynecological oncology.
- Open Access
- 21 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 74, 75968
Nitroxoline: A "Re-Emerging" Antibacterial Agent in the Prevention of Recurrent Urinary Tract Infection Based on Updated Worldwide Guidelines
Introduction. Urinary tract infections (UTIs) represent a critical global healthcare challenge, impacting over 404 million individuals annually. Escalating antimicrobial resistance among primary uropathogens, particularly to fluoroquinolones and broad-spectrum beta-lactams, has driven a critical paradigm shift toward antibiotic-sparing agents. Nitroxoline (5-nitro-8-hydroxyquinoline), an oral uroantiseptic, has re-emerged as a promising therapeutic alternative. Material and methods. This narrative review synthesizes current clinical and microbiological evidence regarding nitroxoline's mechanism of action, pharmacokinetics, safety profile, and resistance rates. Furthermore, it evaluates the drug's therapeutic positioning across updated international clinical guidelines published up to May 2026. Results. Nitroxoline exhibits broad-spectrum activity against Enterobacterales (including ESBL strains), urogenital mycoplasmas, and Candida species. Its antimicrobial effect is driven by the chelation of essential divalent metallic cations, which inhibits bacterial RNA polymerase, reduces biofilm synthesis, inhibits metallo-beta-lactamases, and impairs mucosal adhesion. Oral nitroxoline achieves rapid, high urinary concentrations with low disruption to native intestinal microflora. Clinical data demonstrate high tolerability (~96%) and a minimal discontinuation rate (~1.3%). Major European consensus guidelines (EAU, AWMF, SSGO) recommend nitroxoline as a first-line oral agent for acute localized cystitis and prophylaxis where available. Guidelines in non-registered regions omit the drug solely due to regional market unavailability. Conclusions. Nitroxoline is a potent, safe, and antibiotic-sparing uroantiseptic that aligns with global antimicrobial stewardship principles. Future efforts should focus on expanding clinical trials and clarifying its pharmacokinetics in renal impairment to fully utilize its therapeutic potential against resistant uropathogens.
- 21 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 74, 75968
Open AccessNitroxoline: A "Re-Emerging" Antibacterial Agent in the Prevention of Recurrent Urinary Tract Infection Based on Updated Worldwide Guidelines
Introduction. Urinary tract infections (UTIs) represent a critical global healthcare challenge, impacting over 404 million individuals annually. Escalating antimicrobial resistance among primary uropathogens, particularly to fluoroquinolones and broad-spectrum beta-lactams, has driven a critical paradigm shift toward antibiotic-sparing agents. Nitroxoline (5-nitro-8-hydroxyquinoline), an oral uroantiseptic, has re-emerged as a promising therapeutic alternative. Material and methods. This narrative review synthesizes current clinical and microbiological evidence regarding nitroxoline's mechanism of action, pharmacokinetics, safety profile, and resistance rates. Furthermore, it evaluates the drug's therapeutic positioning across updated international clinical guidelines published up to May 2026. Results. Nitroxoline exhibits broad-spectrum activity against Enterobacterales (including ESBL strains), urogenital mycoplasmas, and Candida species. Its antimicrobial effect is driven by the chelation of essential divalent metallic cations, which inhibits bacterial RNA polymerase, reduces biofilm synthesis, inhibits metallo-beta-lactamases, and impairs mucosal adhesion. Oral nitroxoline achieves rapid, high urinary concentrations with low disruption to native intestinal microflora. Clinical data demonstrate high tolerability (~96%) and a minimal discontinuation rate (~1.3%). Major European consensus guidelines (EAU, AWMF, SSGO) recommend nitroxoline as a first-line oral agent for acute localized cystitis and prophylaxis where available. Guidelines in non-registered regions omit the drug solely due to regional market unavailability. Conclusions. Nitroxoline is a potent, safe, and antibiotic-sparing uroantiseptic that aligns with global antimicrobial stewardship principles. Future efforts should focus on expanding clinical trials and clarifying its pharmacokinetics in renal impairment to fully utilize its therapeutic potential against resistant uropathogens.
- Open Access
- 18 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
THE POTENTIAL ROLE OF L-CARNITINE SUPPLEMENTATION IN MANAGEMENT OF POLYENDOCRINE METABOLIC OVARIAN SYNDROME
Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as polycystic ovary syndrome, is a common endocrine and metabolic disorder affecting women of reproductive age, characterized by hyperandrogenism, ovulatory dysfunction, and insulin resistance. Despite its high prevalence, its pathophysiology remains incompletely understood, and current therapies are largely symptomatic. Increasing evidence implicates mitochondrial dysfunction, oxidative stress, and chronic low-grade inflammation in disease development. In this context, L-carnitine, a key regulator of mitochondrial fatty acid transport and energy metabolism, has emerged as a potential adjunctive therapeutic agent. This narrative review summarizes current evidence on the role of L-carnitine and its derivatives in PMOS, integrating findings from randomized controlled trials, observational studies, systematic reviews, and preclinical models. Available data suggest that L-carnitine supplementation may improve metabolic parameters, including insulin resistance and lipid profiles, while exerting antioxidant and anti-inflammatory effects in ovarian tissue. However, evidence regarding endocrine and fertility outcomes remains inconsistent. Although preclinical studies strongly support biological plausibility, clinical evidence is limited by heterogeneity in study design, small sample sizes, and reliance on surrogate endpoints. L-carnitine should therefore be considered a promising adjunct rather than a standard treatment for PMOS. Further large-scale randomized controlled trials are required to define optimal dosing, formulation, and patient subgroups most likely to benefit.
- 18 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessTHE POTENTIAL ROLE OF L-CARNITINE SUPPLEMENTATION IN MANAGEMENT OF POLYENDOCRINE METABOLIC OVARIAN SYNDROME
Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as polycystic ovary syndrome, is a common endocrine and metabolic disorder affecting women of reproductive age, characterized by hyperandrogenism, ovulatory dysfunction, and insulin resistance. Despite its high prevalence, its pathophysiology remains incompletely understood, and current therapies are largely symptomatic. Increasing evidence implicates mitochondrial dysfunction, oxidative stress, and chronic low-grade inflammation in disease development. In this context, L-carnitine, a key regulator of mitochondrial fatty acid transport and energy metabolism, has emerged as a potential adjunctive therapeutic agent. This narrative review summarizes current evidence on the role of L-carnitine and its derivatives in PMOS, integrating findings from randomized controlled trials, observational studies, systematic reviews, and preclinical models. Available data suggest that L-carnitine supplementation may improve metabolic parameters, including insulin resistance and lipid profiles, while exerting antioxidant and anti-inflammatory effects in ovarian tissue. However, evidence regarding endocrine and fertility outcomes remains inconsistent. Although preclinical studies strongly support biological plausibility, clinical evidence is limited by heterogeneity in study design, small sample sizes, and reliance on surrogate endpoints. L-carnitine should therefore be considered a promising adjunct rather than a standard treatment for PMOS. Further large-scale randomized controlled trials are required to define optimal dosing, formulation, and patient subgroups most likely to benefit.
- Open Access
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74864
The future of Escherichia coli vaccines in prevention of recurrent Urinary Tract Disease based on the newest guidelines worldwide.
Background: Recurrent urinary tract infections (rUTIs), primarily caused by uropathogenic Escherichia coli (UPEC), pose a major global burden. Rising antimicrobial resistance creates an urgent need for non-antibiotic prophylactic strategies, accelerating interest in immunotherapeutics and vaccines. Aim: To evaluate the clinical standing of E. coli immunoprophylaxis in rUTI management under updated 2026 global guidelines, synthesize trial data on historical bacterial extracts, address methodological challenges, and explore emerging target-specific vaccines. Methods: A narrative literature search was conducted using PubMed and Google Scholar for English- and Polish-language studies published up to May 2026, targeting keywords such as "OM-89", "Uro-Vaxom", "E. coli immunotherapy", and "recurrent UTI". Eligible literature included randomized controlled trials, observational studies, systematic reviews, preclinical models, and clinical guidelines. Results: UPEC relies on type 1 fimbrial adhesin (FimH) to adhere to bladder uroepithelium and form intracellular bacterial communities (IBCs). Clinically, the oral extract Uro-Vaxom (OM-89) has historically reduced rUTI frequency and dysuria. However, study heterogeneity and inconsistent outcomes led the European Association of Urology (EAU) to downgrade OM-89's recommendation from strong to weak in 2026. Concurrently, novel subunit vaccines targeting FimH (e.g., adjuvanted FimCH) show promising safety and immunogenicity in early trials, paving the way for Phase 2 evaluation. Conclusions: While OM-89 remains a key non-antibiotic option, updated guidelines highlight the need for standardized, high-quality trials to confirm its efficacy. Next-generation FimH subunit vaccines offer a targeted immunotherapeutic strategy to break the rUTI cycle without driving antimicrobial resistance.
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74864
Open AccessThe future of Escherichia coli vaccines in prevention of recurrent Urinary Tract Disease based on the newest guidelines worldwide.
Background: Recurrent urinary tract infections (rUTIs), primarily caused by uropathogenic Escherichia coli (UPEC), pose a major global burden. Rising antimicrobial resistance creates an urgent need for non-antibiotic prophylactic strategies, accelerating interest in immunotherapeutics and vaccines. Aim: To evaluate the clinical standing of E. coli immunoprophylaxis in rUTI management under updated 2026 global guidelines, synthesize trial data on historical bacterial extracts, address methodological challenges, and explore emerging target-specific vaccines. Methods: A narrative literature search was conducted using PubMed and Google Scholar for English- and Polish-language studies published up to May 2026, targeting keywords such as "OM-89", "Uro-Vaxom", "E. coli immunotherapy", and "recurrent UTI". Eligible literature included randomized controlled trials, observational studies, systematic reviews, preclinical models, and clinical guidelines. Results: UPEC relies on type 1 fimbrial adhesin (FimH) to adhere to bladder uroepithelium and form intracellular bacterial communities (IBCs). Clinically, the oral extract Uro-Vaxom (OM-89) has historically reduced rUTI frequency and dysuria. However, study heterogeneity and inconsistent outcomes led the European Association of Urology (EAU) to downgrade OM-89's recommendation from strong to weak in 2026. Concurrently, novel subunit vaccines targeting FimH (e.g., adjuvanted FimCH) show promising safety and immunogenicity in early trials, paving the way for Phase 2 evaluation. Conclusions: While OM-89 remains a key non-antibiotic option, updated guidelines highlight the need for standardized, high-quality trials to confirm its efficacy. Next-generation FimH subunit vaccines offer a targeted immunotherapeutic strategy to break the rUTI cycle without driving antimicrobial resistance.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
ATOGEPANT IN MIGRAINE PREVENTION: A NARRATIVE REVIEW OF PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY
Migraine is a neurological disorder that involves trigeminal and vascular mechanisms. Pain associated with it is not the only issue. Migraine comes with a significant socioeconomic burden – reduced daily functioning, work productivity and general quality of life. Treatment options for migraine include acute and preventive treatment. Conventional preventive treatments are not always the best option, considering adverse effects, contraindications, quite late benefits and poor long-term adherence. The pathophysiology of migraine led us to the current main therapeutic target – calcitonin gene-related peptide (CGRP). Gepants, including atogepant, are CGRP signaling antagonists. This narrative review analyzes atogepant’s pharmacological profile, currently available evidence about clinical efficacy, tolerability and place of atogepant in migraine management.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessATOGEPANT IN MIGRAINE PREVENTION: A NARRATIVE REVIEW OF PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY
Migraine is a neurological disorder that involves trigeminal and vascular mechanisms. Pain associated with it is not the only issue. Migraine comes with a significant socioeconomic burden – reduced daily functioning, work productivity and general quality of life. Treatment options for migraine include acute and preventive treatment. Conventional preventive treatments are not always the best option, considering adverse effects, contraindications, quite late benefits and poor long-term adherence. The pathophysiology of migraine led us to the current main therapeutic target – calcitonin gene-related peptide (CGRP). Gepants, including atogepant, are CGRP signaling antagonists. This narrative review analyzes atogepant’s pharmacological profile, currently available evidence about clinical efficacy, tolerability and place of atogepant in migraine management.
- Open Access
- 15 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 69, 74214
Effects of creatine on strength, muscle mass, post-exercise recovery and anaerobic capacity in women - literature review
Introduction: Creatine is one of the most commonly used ergogenic supplements in sport and physical activity. Its primary role is associated with energy metabolism through increasing phosphocreatine stores and supporting rapid ATP resynthesis. Although the effects of creatine supplementation have been extensively studied in men, increasing attention is currently being paid to its influence on women, especially regarding muscle strength, muscle mass, post-exercise recovery, and anaerobic performance. Materials and methods: This study is a narrative literature review based on the analysis of scientific articles concerning creatine supplementation in women. The reviewed studies included physically active women, athletes, and older women participating in resistance or high-intensity exercise programs. Meta-analyses, systematic reviews, randomized control trials, systematic and literature reviews, from past 18 years were analyzed. Aim of the study: The aim of this study was to evaluate the effects of creatine supplementation in women, with particular emphasis on muscle strength, muscle mass, post-exercise recovery, and anaerobic performance. Conclusions: In summary, the available data suggest that creatine supplementation may benefit women in terms of muscle strength and anaerobic performance, particularly when combined with regular training. The effects on muscle mass gain and post-workout recovery remain less conclusive. Despite the growing number of studies, there is still a need for further, well-designed research involving women to more accurately determine the effects of creatine depending on age, physical activity level, and hormonal changes.
- 15 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 69, 74214
Open AccessEffects of creatine on strength, muscle mass, post-exercise recovery and anaerobic capacity in women - literature review
Introduction: Creatine is one of the most commonly used ergogenic supplements in sport and physical activity. Its primary role is associated with energy metabolism through increasing phosphocreatine stores and supporting rapid ATP resynthesis. Although the effects of creatine supplementation have been extensively studied in men, increasing attention is currently being paid to its influence on women, especially regarding muscle strength, muscle mass, post-exercise recovery, and anaerobic performance. Materials and methods: This study is a narrative literature review based on the analysis of scientific articles concerning creatine supplementation in women. The reviewed studies included physically active women, athletes, and older women participating in resistance or high-intensity exercise programs. Meta-analyses, systematic reviews, randomized control trials, systematic and literature reviews, from past 18 years were analyzed. Aim of the study: The aim of this study was to evaluate the effects of creatine supplementation in women, with particular emphasis on muscle strength, muscle mass, post-exercise recovery, and anaerobic performance. Conclusions: In summary, the available data suggest that creatine supplementation may benefit women in terms of muscle strength and anaerobic performance, particularly when combined with regular training. The effects on muscle mass gain and post-workout recovery remain less conclusive. Despite the growing number of studies, there is still a need for further, well-designed research involving women to more accurately determine the effects of creatine depending on age, physical activity level, and hormonal changes.
- Open Access
- 14 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 64, 73766
Overcoming Post-Operative Anabolic Resistance: The Integrated Role of Protein Nutrition and Physical Rehabilitation in Orthopedic Patients
Introduction: Orthopedic surgery and subsequent disuse trigger a severe systemic stress response. This hostile environment induces anabolic resistance. Consequently, skeletal muscle loses its sensitivity to nutritional inputs and mechanical loading. At the molecular level, the process is driven by a failure of the mTORC1 signaling pathway and accelerated FOXO-mediated proteolysis. Ultimately, these mechanisms cause rapid muscle atrophy, a negative nitrogen balance, and functional decline. Aim: The aim of this narrative review is to examine the molecular and physiological mechanisms of post-operative anabolic resistance and to evaluate how perioperative protein nutrition and mechanical loading combine to restore functional capacity in orthopedic patients. Material and methods: This study was conducted as a narrative review of literature addressing the pathophysiology of post-operative anabolic resistance and integrated recovery strategies in orthopedic patients. A comprehensive literature search was performed using the electronic databases PubMed/MEDLINE, Scopus, Web of Science, the Cochrane Library, and Google Scholar. Results: Post-operative anabolic resistance represents a failure of the mTORC1 signaling path, elevating the leucine threshold needed for net muscle balance. Mechanical loading during rehabilitation acutely enhances muscle sensitivity to amino acids. Consequently, clinical outcomes are optimized when elevated, leucine-rich protein doses (30–40 g/meal, totaling 1.2–2.0 g/kg/day) are evenly distributed. Compared to integrated interventions, standalone nutritional or mechanical protocols exhibit significant variability in their functional endpoints. Conclusions: Post-operative muscle loss is a multi-factorial process requiring a multidisciplinary approach. Overcoming anabolic resistance and accelerating recovery requires fully integrating nutrition into orthopedic rehabilitation, rather than treating it as an isolated intervention.
- 14 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 64, 73766
Open AccessOvercoming Post-Operative Anabolic Resistance: The Integrated Role of Protein Nutrition and Physical Rehabilitation in Orthopedic Patients
Introduction: Orthopedic surgery and subsequent disuse trigger a severe systemic stress response. This hostile environment induces anabolic resistance. Consequently, skeletal muscle loses its sensitivity to nutritional inputs and mechanical loading. At the molecular level, the process is driven by a failure of the mTORC1 signaling pathway and accelerated FOXO-mediated proteolysis. Ultimately, these mechanisms cause rapid muscle atrophy, a negative nitrogen balance, and functional decline. Aim: The aim of this narrative review is to examine the molecular and physiological mechanisms of post-operative anabolic resistance and to evaluate how perioperative protein nutrition and mechanical loading combine to restore functional capacity in orthopedic patients. Material and methods: This study was conducted as a narrative review of literature addressing the pathophysiology of post-operative anabolic resistance and integrated recovery strategies in orthopedic patients. A comprehensive literature search was performed using the electronic databases PubMed/MEDLINE, Scopus, Web of Science, the Cochrane Library, and Google Scholar. Results: Post-operative anabolic resistance represents a failure of the mTORC1 signaling path, elevating the leucine threshold needed for net muscle balance. Mechanical loading during rehabilitation acutely enhances muscle sensitivity to amino acids. Consequently, clinical outcomes are optimized when elevated, leucine-rich protein doses (30–40 g/meal, totaling 1.2–2.0 g/kg/day) are evenly distributed. Compared to integrated interventions, standalone nutritional or mechanical protocols exhibit significant variability in their functional endpoints. Conclusions: Post-operative muscle loss is a multi-factorial process requiring a multidisciplinary approach. Overcoming anabolic resistance and accelerating recovery requires fully integrating nutrition into orthopedic rehabilitation, rather than treating it as an isolated intervention.